Diarrhoea on Wegovy 1.7mg: What to Expect and When to Act

Diarrhoea after a dose increase is common and usually settles within one to two weeks as your body adjusts to 1.7mg semaglutide.
Severe or persistent diarrhoea can cause dehydration — staying on top of fluids matters more than it might seem.
If you develop severe abdominal pain alongside any GI upset, get medical help promptly: this can occasionally signal acute pancreatitis, a serious but infrequent side effect the MHRA has specifically flagged for GLP-1 medicines.
You can report unexpected or serious side effects via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk — it helps regulators monitor medicines in real-world use.

Diarrhoea is one of the more common side effects people notice after moving to the 1.7mg Wegovy dose. Loose stools typically arrive in the first week or two after a dose increase, settle gradually for most people, and rarely require stopping treatment. That said, knowing what's expected, what isn't, and when to call for help makes a real difference to how you manage those early weeks. Wegovy (semaglutide) is a prescription-only medicine, and decisions about managing side effects at this dose always sit with your prescriber.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How to manage loose stools at 1.7mg, and what the warning signs look like

Why the 1.7mg step tends to bring GI side effects back

Moving from 1mg to 1.7mg is a meaningful jump in dose. Semaglutide works partly by slowing the rate at which food leaves your stomach and by acting on appetite-regulating receptors in the gut and brain. At each new dose level, those gut effects reassert themselves before your digestive system has had time to adapt. The result, for many people, is a short window of looser stools, urgency, or more frequent trips to the bathroom.

This isn't unique to 1.7mg. You may have noticed something similar when you moved from 0.5mg to 1mg. The pattern tends to be: a few days of disruption, gradual improvement, and then a new normal. The NHS semaglutide information page lists diarrhoea as a common side effect of the medicine across its titration schedule.

Eating smaller portions, avoiding high-fat or very rich meals, and giving yourself a little more time between eating and any activity that might aggravate things can all take the edge off. None of that replaces a conversation with your prescriber, but it's worth trying before concluding 1.7mg isn't right for you. Many people who struggle in week one are fine by week three. For more on the dose itself and how it fits the wider titration sequence, the Wegovy 1.7mg overview is a useful reference.

The decision you're actually facing: push through, pause, or report it?

A question our prescribers hear most weeks is some version of: "It's been two weeks and I'm still not right, do I carry on?" The honest answer depends on a few things. Duration matters. Two to three weeks of mild-to-moderate loose stools after a dose increase is within the range of what the clinical evidence shows. Beyond three to four weeks without improvement, that's worth raising with your prescriber rather than assuming it will resolve.

Severity matters too. Mild means inconvenient. Moderate means it's affecting your day. Severe means you can't leave the house, you're losing significant fluid, or you're feeling dizzy and lightheaded. The last of those needs prompt clinical attention, not reassurance from an article.

If 1.7mg is genuinely not tolerable, staying at the previous dose for longer is a legitimate clinical option. The Wegovy dosing schedule is a guide, not a rigid countdown. Your prescriber can advise on timing. What you should not do is self-manage by skipping injections without telling anyone, that changes your clinical picture in ways that matter for your next review.

If you're curious how the 1.7mg to 2.4mg move compares in terms of side effect burden, the guide on stepping up to 2.4mg covers that transition specifically, and our page on diarrhoea at the 2.4mg dose goes into more detail about what to expect once you reach the maintenance level.

When diarrhoea on Wegovy 1.7mg becomes a medical concern

Most diarrhoea on semaglutide is uncomfortable but not dangerous. There are situations where it becomes something to act on quickly.

Dehydration is the most common risk. Repeated loose stools remove fluid faster than many people replace it. Thirst, a dry mouth, dark urine, or feeling light-headed when you stand are signs you need to drink more and potentially speak to someone. If you can't keep fluids down at all, that warrants same-day contact with a GP or pharmacy.

Severe abdominal pain is a different matter. In January 2026, the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines including semaglutide. The warning sign is intense, persistent stomach pain (often reaching through to the back) that may or may not come with vomiting. This is not typical GI discomfort. If you experience it, stop eating and get medical help the same day. Don't wait for your next prescription review.

Signs of an allergic reaction (swelling, difficulty breathing, a spreading rash) are also a reason to seek emergency help immediately. Diarrhoea is listed among Wegovy's common side effects; serious hypersensitivity reactions are rare but documented. If something feels wrong in a way that goes beyond GI upset, trust that instinct and call 111 or 999 as the severity warrants. Unexpected or serious reactions can also be reported through the MHRA Yellow Card scheme, patient reports genuinely contribute to ongoing safety monitoring.

Practical things that actually help

Staying hydrated is the single most useful thing you can do. Water is fine; oral rehydration sachets are better if you're losing a lot of fluid. Avoid caffeine and alcohol while symptoms are active, both irritate the gut and make fluid loss worse.

Smaller, lower-fat meals tend to produce fewer GI symptoms on semaglutide. You're probably already eating less due to appetite suppression, but the composition of what you eat matters too. Greasy or very rich food moves through a slowed GI tract in a way that can worsen loose stools specifically. Keeping a rough note of what you ate before a bad day can help you spot a pattern worth raising with your prescriber.

Some people find that taking their injection at night means the worst GI effects happen while they're asleep. That's anecdotal rather than clinical guidance, but it's a question worth putting to your prescriber. If you're also wondering where 1.7mg sits within the full treatment programme, our page on the average dose of Wegovy explains how most people progress through the titration schedule and what dose they typically end up at. For context on how this dose compares to the 1mg experience many people come from, the page on diarrhoea at the 1mg dose is worth reading alongside this one.

Ultimately, if you're unsure whether what you're experiencing is normal or needs attention, the right move is to speak with a clinician. Our prescribers cover exactly this kind of question as part of the review process. You can start a free consultation and get a same-day clinical review from a GPhC-registered prescriber who can assess your specific situation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions